Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:EU:CYAD

1 2 3 4 5 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
08/02/2024	22h01	GlobeNewswire Inc.	Celyad Oncology announces intention to terminate SEC reporting obligations	EU:CYAD	Celyad Oncology SA
16/01/2024	22h01	GlobeNewswire Inc.	Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook	EU:CYAD	Celyad Oncology SA
20/12/2023	22h01	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
15/12/2023	22h01	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
04/12/2023	22h01	GlobeNewswire Inc.	Celyad announces management change	EU:CYAD	Celyad Oncology SA
01/12/2023	12h42	GlobeNewswire Inc.	Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
21/11/2023	22h00	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
14/11/2023	22h00	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
09/11/2023	07h00	GlobeNewswire Inc.	Celyad Oncology reports third quarter 2023 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
25/09/2023	22h01	GlobeNewswire Inc.	Celyad Oncology announces the termination of its American Depository Receipt program	EU:CYAD	Celyad Oncology SA
15/09/2023	22h01	GlobeNewswire Inc.	Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
12/09/2023	22h01	GlobeNewswire Inc.	Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
07/09/2023	22h01	GlobeNewswire Inc.	Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
05/09/2023	22h00	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	EU:CYAD	Celyad Oncology SA
04/09/2023	22h00	GlobeNewswire Inc.	Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights	EU:CYAD	Celyad Oncology SA
24/08/2023	22h00	GlobeNewswire Inc.	Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders	EU:CYAD	Celyad Oncology SA
15/05/2023	22h01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq delisting notice	EU:CYAD	Celyad Oncology SA
05/05/2023	07h00	GlobeNewswire Inc.	Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq	EU:CYAD	Celyad Oncology SA
05/05/2023	07h00	GlobeNewswire Inc.	Celyad Oncology reports first quarter 2023 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
24/04/2023	22h01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price	EU:CYAD	Celyad Oncology SA
04/04/2023	22h01	GlobeNewswire Inc.	Celyad Oncology announces receipt of Nasdaq notice	EU:CYAD	Celyad Oncology SA
24/03/2023	07h00	GlobeNewswire Inc.	Celyad Oncology appoints Georges Rawadi as its new CEO	EU:CYAD	Celyad Oncology SA
23/03/2023	22h01	GlobeNewswire Inc.	Celyad Oncology reports full year 2022 financial results and recent business highlights	EU:CYAD	Celyad Oncology SA
17/03/2023	22h01	GlobeNewswire Inc.	Celyad Oncology to announce full year 2022 financial results and host conference call	EU:CYAD	Celyad Oncology SA
15/03/2023	07h00	GlobeNewswire Inc.	Celyad Oncology announces non-cash impairment	EU:CYAD	Celyad Oncology SA
01/03/2023	07h00	GlobeNewswire Inc.	REPEAT -- Celyad Oncology SA - Letter to Shareholders	EU:CYAD	Celyad Oncology SA
28/02/2023	17h16	GlobeNewswire Inc.	Celyad Oncology SA - Letter to Shareholders	EU:CYAD	Celyad Oncology SA
09/02/2023	07h00	GlobeNewswire Inc.	Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01	EU:CYAD	Celyad Oncology SA
03/02/2023	07h00	GlobeNewswire Inc.	Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook	EU:CYAD	Celyad Oncology SA
21/12/2022	07h00	GlobeNewswire Inc.	Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property	EU:CYAD	Celyad Oncology SA

Showing the most relevant articles for your search:EU:CYAD

1 2 3 4 5 Next >>

Health Care Select Sector

Euro vs Sterling

Deutsche Telekom

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen